Company type
Limited Corporation (APS)
Established
2001
Size
Large
Employees
966
Revenue
3,069 MDKK
Gross profit
584 MDKK
Operating Profit (EBIT)
288 MDKK
Profit for the year
213 MDKK
Equity
4,079 MDKK
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!

Rank Profit for the year

Rank in industry
2/135
"Top 10%"
Rank in Denmark
1,030/333,113
"Top 10%"

Top management - top 3

Lars Petersen 2Director

Board - top 3

Martin Edward Meeson 2Chairman of board
Lars Petersen 2Boardmember
Takatoshi Ishikawa 1Boardmember

Legal owners - top 3

100%Fujifilm Diosynth Biotechnologies Holdings Denmark Aps

Rights certificate

Selskabet tegnes af et bestyrelsesmedlem alene. Bestyrelsen kan via fuldmagt bemyndige en person eller flere personer til at tegne på Selskabets vegne.

Company information based on CVR

NameFujifilm Diosynth Biotechnologies Denmark Aps
CVR26060702
AddressBiotek Allé 1, 3400 Hillerød
IndustryManufacture of pharmaceutical preparations [212000]
Established01-06-2001 (22 yr)
Company typeLimited Corporation (APS)
Number of employees1181 (man years:1168)
Advertising protectionNo
AuditorKpmg P/S since 01-08-2019
Financial statement period01-04 to 31-03
Company capital390,000 DKK
385,000 DKK (10-04-2008 - 06-05-2008)
380,000 DKK (15-01-2008 - 09-04-2008)
375,000 DKK (01-10-2007 - 14-01-2008)
370,000 DKK (07-08-2007 - 30-09-2007)
365,000 DKK (20-04-2007 - 06-08-2007)
Articles of assoc. last27-10-2021

Member of industries

Purpose

Selskabets formål er at drive produktions- og handelsvirksomhed og at besidde kapitalandele i andre virksomheder samt at drive anden virksomhed, der efter direktionens skøn er forbunden hermed.

Financial Statement

 202220212020
Currency/unit000' DKK000' DKK000' DKK
Revenue
3,068,983
+13%
2,727,431
-
2,039,469
-
Gross Profit
583,823
+18%
494,437
-
65,121
-
Profit for the year
213,460
+106%
103,550
-
-176,316
-
Equity
4,078,878
+6%
3,865,418
-
3,761,868
-
Total Assets
8,455,622
+45%
5,848,427
-
5,508,130
-

Mangement review

A significant improvement in the activities in the business areas resulting in higher than expected revenue and profit.
Revenue and Profit
The company delivered a total revenue of DKK 3,069.0 million in financial year 2021/22 compared to DKK 2,727.4 million in the previous period.

The growth in revenue was 12.5%, which exceeded expectations.

Profit before tax was DKK 271.9 million compared to DKK 132.8 million in the previous year. The improvement can be attributed to the increased manufacturing activities in the drug substance manufacturing area.

The revenue in 2020/21 was negatively impacted throughout the year by USD exchange rates. The revenue in 2021/22 has been less impacted.
Net Profit
FDBD reported net profit of DKK 213.5 million in 2021/22 compared to DKK 103.6 million in 2020/21.

Investments
FDBD invested a total of DKK 2,617.9 million in tangible fixed assets in 2021/22. This is a significant increase compared to 2020/21. The investments are covering the expansion of the facility in building for the future project as well as the operational capital investment to support the continuous manufacturing. The impact of COVID-19 on the expansion was managed and mitigated during the year with the use of on-site testing, tracking of positive cases as well as working from home where possible.
Total assets increased in 2021/22. At year-end the total assets were DKK 8,455.6 million compared to the DKK 5,848.4 million the year before.
Equity
At the end of the financial year the equity shows DKK 4,078.9 million. The equity ratio decreased from 66.1% in 2020/21 to 48.2% in 2021/22.
Non-financial matters
Employees
We strive to be an attractive workplace, who can attract and retain the right employees with the right knowledge. This is essential to our current and future success as a company.

At the end of 2021/22 the company had 969 full time employees, which was 88 employees more than the 881 employees the year before. This increase in employees is driven by increase in business and expansion activities on the site. All of the employees work from the company’s site in Hillerød.
29-09-2022

Map